Article Information
History
- June 17, 2022.
Article Versions
- Version 1 (September 28, 2020 - 04:00).
- Version 2 (October 23, 2021 - 23:49).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Jacob James Rich, MA1,2,*,
- Robert Capodilupo, MPhil3,
- Michael Schemenaur, MA4 and
- Jeffrey A. Singer, MD5
- 1Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
- 2Drug Policy Project, Reason Foundation, Los Angeles, California, USA
- 3Yale Law School, New Haven, Connecticut, USA
- 4Department of Economics, Eller College of Management, University of Arizona, Tucson, Arizona, USA
- 5Department of Health Policy Studies, Cato Institute, Washington, District of Columbia, USA
- ↵*Correspondence Jacob James Rich, jacob.j.rich{at}case.edu, Wolstein Research Building 2520, 2103 Cornell Road, Cleveland, OH 44106